Duke University Medical Center, Durham, North Carolina, United States of America.
Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS One. 2021 Jan 20;16(1):e0245169. doi: 10.1371/journal.pone.0245169. eCollection 2021.
Anti-inflammatory cytokine IL-10 suppresses pro-inflammatory IL-12b expression after Lipopolysaccharide (LPS) stimulation in colonic macrophages, as part of the innate immunity Toll-Like Receptor (TLR)-NF-κB activation system. This homeostatic mechanism limits excess inflammation in the intestinal mucosa, as it constantly interacts with the gut flora. This effect is reversed with Histone Deacetylase 3 (HDAC3), a class I HDAC, siRNA, suggesting it is mediated through HDAC3. Given alveolar macrophages' prominent role in Acute Lung Injury (ALI), we aim to determine whether a similar regulatory mechanism exists in the typically sterile pulmonary microenvironment.
Levels of mRNA and protein for IL-10, and IL-12b were determined by qPCR and ELISA/Western Blot respectively in naïve and LPS-stimulated alveolar macrophages. Expression of the NF-κB intermediaries was also similarly assessed. Experiments were repeated with AS101 (an IL-10 protein synthesis inhibitor), MS-275 (a selective class 1 HDAC inhibitor), or both.
LPS stimulation upregulated all proinflammatory mediators assayed in this study. In the presence of LPS, inhibition of IL-10 and/or class 1 HDACs resulted in both synergistic and independent effects on these signaling molecules. Quantitative reverse-transcriptase PCR on key components of the TLR4 signaling cascade demonstrated significant diversity in IL-10 and related gene expression in the presence of LPS. Inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the transcription of MyD88, IRAK1, Rela and the NF-κB p50 subunit. Interestingly, by quantitative ELISA inhibition of IL-10 secretion and/or class 1 HDACs in the presence of LPS independently affected the secretion of not only IL-10, IL-12b, and TNFα, but also proinflammatory mediators CXCL2, IL-6, and MIF. These results suggest that IL-10 and class 1 HDAC activity regulate both independent and synergistic mechanisms of proinflammatory cytokine/chemokine signaling.
Alveolar macrophages after inflammatory stimulation upregulate both IL-10 and IL-12b production, in a highly class 1 HDAC-dependent manner. Class 1 HDACs appear to help maintain the balance between the pro- and anti-inflammatory IL-12b and IL-10 respectively. Class 1 HDACs may be considered as targets for the macrophage-initiated pulmonary inflammation in ALI in a preclinical setting.
抗炎细胞因子白细胞介素-10(IL-10)抑制脂多糖(LPS)刺激结肠巨噬细胞中促炎白细胞介素-12b(IL-12b)的表达,作为先天免疫 Toll 样受体(TLR)-NF-κB 激活系统的一部分。这种体内平衡机制限制了肠道黏膜中过度的炎症反应,因为它与肠道菌群不断相互作用。用组蛋白去乙酰化酶 3(HDAC3),一种 I 类 HDAC 的 siRNA 逆转这种效应,表明它是通过 HDAC3 介导的。鉴于肺泡巨噬细胞在急性肺损伤(ALI)中发挥着突出的作用,我们旨在确定在通常无菌的肺微环境中是否存在类似的调节机制。
通过 qPCR 和 ELISA/Western Blot 分别测定未刺激和 LPS 刺激的肺泡巨噬细胞中 IL-10 和 IL-12b 的 mRNA 和蛋白水平。同样评估了 NF-κB 中间产物的表达。用 AS101(IL-10 蛋白合成抑制剂)、MS-275(选择性 I 类 HDAC 抑制剂)或两者重复实验。
LPS 刺激上调了本研究中测定的所有促炎介质。在 LPS 的存在下,抑制 IL-10 和/或 I 类 HDACs 对这些信号分子产生协同和独立的影响。TLR4 信号级联的关键成分的定量逆转录酶 PCR 显示,在 LPS 存在下,IL-10 和相关基因的表达存在显著差异。在 LPS 存在下,抑制 IL-10 分泌和/或 I 类 HDACs 独立影响 MyD88、IRAK1、Rela 和 NF-κB p50 亚基的转录。有趣的是,通过定量 ELISA,在 LPS 存在下抑制 IL-10 分泌和/或 I 类 HDACs 独立影响不仅 IL-10、IL-12b 和 TNFα 的分泌,还影响促炎介质 CXCL2、IL-6 和 MIF 的分泌。这些结果表明,IL-10 和 I 类 HDAC 活性调节促炎细胞因子/趋化因子信号的独立和协同机制。
在炎症刺激后,肺泡巨噬细胞以上调 IL-10 和 IL-12b 的产生为特征,这一过程高度依赖于 I 类 HDAC。I 类 HDAC 似乎有助于维持促炎 IL-12b 和抗炎 IL-10 之间的平衡。I 类 HDAC 可被视为临床前 ALI 中肺巨噬细胞起始的肺部炎症的靶点。